Nuevolution AB (publ) announces timing for the fourth quarter release and webcast


Stockholm, 29 August 2016 – Nuevolution AB (publ) (NUE.ST) announces today that
it will report its fourth quarter 2015/16 financial results on Tuesday 6
September at 8:00 CEST.

On Tuesday 6 September at 13:00 CEST, the company’s executive management will
host a conference call and webcast discussion of the results and provide an
update on the pipeline programs and partnering activities. Access to the event
can be obtained as follows:

LIVE access on Tuesday 6 September at 13:00 CEST

Telephone numbers:

SE: +46 85 664 2669

DK: +45 8233 3178

UK: +44 20 3008 9808

US: +1 855 7532 235

Webcast will be available at www.nuevolution.com in the Investors section and at
www.financialhearings.com

REPLAY access

Webcast replay will be available at www.nuevolution.com in the Investors section
and at www.financialhearings.com

For more information, please contact:

Alex Haahr Gouliaev, CEO

Phone: +45 3913 0902

Email: ahg@nuevolution.com

Henrik Damkjær Simonsen, CFO

Phone: +45 3913 0947

Email: hs@nuevolution.com

Information about Nuevolution AB (publ)

Nuevolution AB (publ) is a leading small molecule drug discovery biotech company
founded in 2001, and headquartered in Copenhagen, Denmark. Nuevolution partners
its discovery platform and programs with pharmaceutical and biotechnology
companies to seek future benefit of patients in need of novel medical treatment
option. Nuevolution’s internal programs are focused on therapeutically important
targets within inflammation, oncology and immuno-oncology.

Nuevolution AB (publ) is required to disclose the information provided herein
pursuant to the Securities Markets Act. The information was sent for publication
on Monday 29 August, 13.00 (CEST).

Nuevolution AB (publ) is listed at Nasdaq First North in Stockholm, Sweden
(ticker: NUE.ST). Västra Hamnen Corporate Finance AB acts as Certified Advisor
to Nuevolution AB (publ). More information about Nuevolution can be found on:
www.nuevolution.com

Attachments

08298028.pdf
GlobeNewswire